Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions

Virchows Archiv

Volumn 434, Issue 6, 1999, Pages 561-568

  Luoma, Jukka S ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atherogenesis; Inducible nitric oxide synthase; Macrophages; Oxidized LDL; Peroxynitrite; Smooth muscle cells

Indexed keywords

LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROTEIN;

ADULT; AGED; AORTA; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CLINICAL ARTICLE; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN TISSUE; LIPID OXIDATION; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ADULT; AGED; ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER;

EID: 0032972299     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050384     Document Type: Article

References (43)

1. 1. Moncada S, Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330
2. 2. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064
3. 3. Radomski MW, Salas E (1995) Nitric oxide - biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 118 [Suppl]:S69-S80
4. 4. Lowenstein CJ, Snyder SH (1992) Nitric oxide, a novel biologic messenger. Cell 70:705-707
5. 5. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R (1992) The participation of nitric oxide in cell free-and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta 1180:73-82
6. 6. Yates MT, Lambert LE, Whitten JP, McDonald I, Mano M, Ku G, Mao SJ (1992) A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett 309:135-138
7. 7. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S (1993) Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334:170-174
8. 8. Malo-Ranta U, Ylä-Herttuala S, Metsä-Ketelä T, Jaakkola O, Moilanen E, Vuorinen P, Nikkari T (1994) Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett 337:179-183
9. 9. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalyanaraman B, Freeman BA (1995) Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 324:15-25
10. 10. Förstermann U, Gloss EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H (1994) Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23:1121-1131
11. 11. Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Böhme E (1991) Brain nitric oxide synthase is a biopterin-and flavin-containing multi-functional oxido-reductase. FEBS Lett 288:187-191
12. 12. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:10480-10484
13. 13. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF (1991) Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD-and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88:7773-7777
14. 14. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:481-487
15. 15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355-1374
16. 16. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG (1995) Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92:898-903
17. 17. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM (1994) Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 91:1044-1048
18. 18. Darley-Usmar V, Wiseman H, Halliwell B (1995) Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 369: 131-135
19. 19. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75:77-85
20. 20. Albina JE (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leuk Biol 58:643-649
21. 21. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9:371-377
22. 22. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steinberg D (1990) Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 87:6959-6963
23. 23. Luoma J, Hiltunen T, Särkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Ylä-Herttuala S (1994) Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 93:2014-2021
24. 24. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Särkioja T, Witztum JL, Steinberg D (1991) Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87:1146-1152
25. 25. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228
26. 26. Maniatis, T, Fritsch, EF, Sambrook, J (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
27. 27. Gown AM, Tsukada T, Ross R (1986) Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125:191-207
28. 28. Tsukada T, Tippens D, Gordon D, Ross R, Gown AM (1987) HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol 126:51-60
29. 29. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325-335
30. 30. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375:81-88
31. 31. Pollock JS, Nakane M, Buttery LD, Martinez A, Springall D, Polak JM, Förstermann U, Murad F (1993) Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265:C1379-1387
32. 32. Kanno K, Hirata Y, Imai T, Iwashina M, Marumo F (1994) Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am J Physiol 267:H2318-2324
33. 33. Busse R, Mulsch A (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87-90
34. 34. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
35. 35. Laitinen M, Zachary I, Breier G, Pakkanen T, Häkkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Ylä-Herttuala S (1997) Vegf gene transfer reduces intimai thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 8:1737-1744
36. 36. Jessup W (1996) Oxidized lipoproteins and nitric oxide. Curr Opin Lipidol 7:274-280
37. 37. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90:1168-1172
38. 38. Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14:753-759
39. 39. Naruse K, Shimizu K, Muramatsu M, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T (1994) Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb 14:746-752
40. 40. Ischiropoulos H, al Mehdi AB (1995) Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 364:279-282
41. 41. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S (1993) Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 330:181-185
42. 42. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, Heinecke JW (1997) Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 272:1433-1436
43. 43. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL (1990) Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10:336-349